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ABSTRACT
OBJECTIVE: To describe diabetes mellitus mortality according to sex and age in a municipality 
in the state of São Paulo, in the period ranging from 2010 to 2014.
METHODS: This was a temporal series ecological study carried out in Ribeirão Preto, state of 
São Paulo. The data was comprised of information on 583 deaths of Ribeirão Preto residents – 
regardless of the place of death – from 2010 to 2014. The data source was the electronic system 
of the Epidemiological Surveillance of the Municipal Health Department of the evaluated 
municipality. Sex, age group, premature death and year of death were chosen as variables. 
Subsequently, age-standardized mortality rates were calculated using the World Health 
Organization’s standard population, in addition to total and average per death potential years 
of life lost.
RESULTS: Mortality due to diabetes mellitus in the municipality increased during the studied 
period. There was a higher occurrence of female deaths, especially in the ≥ 80 years age group. 
The highest rates of age-standardized mortality were male. For both sexes, there was an annual 
mean increase of 9% in premature mortality during the studied period. Diabetes decreased life 
expectancy by 10 years.
CONCLUSIONS: As a diagnosis of local health care, the significant increase in age-
standardized mortality rates, premature mortality and potential years of life lost in the studied 
municipality point to the need for improvements in health promotion and disease prevention 
measures. It is our hope that the results presented in this study contribute to the monitoring 
of mortality rates in the coming years.
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INTRODUCTION
Due to being associated with high mortality rates, cardiovascular diseases, neoplasms, 
chronic respiratory diseases and diabetes mellitus (DM) are considered the main chronic 
noncommunicable diseases (CNCDs). The World Health Organization (WHO) has estimated a 
total of 38 million deaths from CNCDs in 2012, corresponding to 70% of all worldwide deaths1.
Among the four major CNCDs in 2012, cardiovascular diseases caused 17.5 million deaths, 
followed by neoplasms (8.2 million), chronic respiratory diseases (4 million) and DM (1.5 
million). Furthermore, 16 million (42%) CNCD deaths were premature and preventable1.
DM in particular has been increasing worldwide. The number of people with DM increased 
from 108 million in 1980 to 422 million in 20142. In 2015, about five million people aged 20–79 
died from DM, more than the sum of infectious-disease deaths in 20133 (1.5 million deaths 
from HIV/AIDS, 1.5 million deaths from tuberculosis, and 0.6 million deaths from malaria). 
A study showed that, from 1980 to 2012, 955,455 people aged 20 years or more died from 
DM in Brazil. The same study also showed that when considering DM as the underlying or 
associated cause of mortality, the number of deaths increased to 1,076,434, reiterating how 
monitoring the DM population is important for the health system4.
Among the policy strategies to reduce the burden of DM mortality are the Global Action 
Plan for the Prevention and Control of NCDs, by the World Health Organization (WHO)5, 
and the Strategic Action Plan to Tackle Noncommunicable Diseases in Brazil, 2011–2022, 
by Brazil’s Ministry of Health. The latter has three pillars: surveillance, health promotion, 
and comprehensive care6.
In the surveillance pillar, a mortality indicator aggregates and organizes information on 
population gaps related to morbidity, mortality and their risk factors. Information, evaluation 
and monitoring aim to define the population’s vulnerability, and subsequently contribute to 
the qualification of health interventions, as well as the reduction of mortality rates7. Monitoring 
should be performed at all system management levels, from the municipal to the national8. 
In view of the above, this study aims to describe DM mortality, according to sex and age, in a 
municipality in the state of São Paulo, from 2010 to 2014. It is our hope that this study is able 
to provide subsidies for DM monitoring, a fundamental activity of the Health Surveillance 
System, and contribute to the development of effective strategies in diabetes education.
METHODS
This was an ecological and time-trend study9, carried out in the city of Ribeirão Preto, located 
in the northeastern region of the state of São Paulo, 313 kilometers from its capital. The 
municipality has a total area of 650 km2 and a population of 604,682 inhabitants, according 
to the 2010 census10.
The study population was comprised of deaths of residents of the municipality, regardless 
of the place of death, taking place from 2010 to 2014. These data were obtained from the 
Epidemiological Surveillance Division of the Municipal Health Department of Ribeirão 
Preto, state of São Pauilo, in 2017, after approval by the Ethics Committee of the School 
of Nursing of the University of São Paulo at Ribeirão Preto (EERP-USP), Process 2,111,771. 
Among 718 DM deaths, 135 were excluded, as the individuals were not residents of the 
studied municipality.
The data were segregated by the following variables: sex (female and male), age (in years) 
classified by age group (0–4; 5–9; 10–14; 15–19; 20–24; 25–29; 30–34; 35–39; 40–44; 45–49; 
50–54; 55–59; 60–64; 65–69; 70–74; 75–79; ≥ 80 years), date of death, and cause of death. Age 
ranges were classified according to the Tab for Windows program (TABWIN), a free piece of 
software developed by Datasus11. The basic cause of death per the death certificate, and DM 
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cases classified as E10 to E14 (according to the WHO’s ICD-10 – International Classification 
of Diseases and Related Health Problems, 10th revision), were included in this study. E10 
refers to insulin-dependent DM; E11, to non-insulin-dependent DM; E12, to malnutrition-
related DM; E13, to other specified types of DM; and E14, to unspecified DM1–12.
The obtained data were imported into Excel spreadsheets, for descriptive treatment and 
subsequent statistical analysis. In the first stage of analysis, deaths of Ribeirão Preto, residents 
were selected for inclusion, based on the deceased’s documented city code. Statistical descriptive 
data analysis was performed using the Statistical Program For Social Sciences (SPSS), version 
22, for Windows. Descriptive data was presented using frequency and percentage of DM deaths 
spanning the 2010 to 2014 period, according to year, sex and age group.
DM age-standardized mortality rates (ASMR) per 100,000 inhabitants were calculated 
according to gender, age group and year of death, using WHO’s standard population and 
the direct standardization method13,14. For individuals with 80 years of age or above, the 
number of deaths and the percentages established by the WHO were added together. 
For premature mortality (people with ≥ 30 and ≤ 69 years of age), the methodology proposed 
by the WHO was employed6. Potential years of life lost (PYLL) were estimated using the 
method proposed by Romeder and McWhinnie15. 
In order to gauge the period’s rate reduction percentages, the annual rate reduction was 
initially calculated by dividing the difference between consecutive year rates by the rate 
in the initial year of the calculation (multiplied by 100). The resulting mean was defined as 
the period’s annual reduction14. 
RESULTS 
In 2010–2014, a total of 583 deaths were attributed to DM in Ribeirão Preto, state of São Paulo. 
The DM type was unspecified for 494 (84.7%) deaths. Acute complications (final character of the 
ICD-10 code: .0 or .1) were attributed to 10 (1.7%) deaths. As for complication types, 161 (34.5%) 
deaths were due to renal complications, 68 (11.7%) due to peripheral circulatory complications, 
52 (8.9%) due to multiple complications, and 24 (4.1%) due to other complications. It should 
be noted that 228 (39.1%) deaths had no record of complications (Table 1).
Most deaths – 321 (55.1%) – were female. The predominant age group was older people over 
80 years of age (n = 194, 33.3%). There was an expressive increase in the total number of 
deaths from 55 years of age onward (Table 2).
Table 1. Absolute number (n) and percentage (%) distribution of deaths by diabetes mellitus, according to ICD-10 classification, Ribeirão 




E10a E11b E12c E13d E14e
Number of deaths n %
Comatose 0 3 0 0 1 4 0.7
.1 Ketoacidosis 0 0 0 0 6 6 1.0
.2 Renal complications 6 34 0 0 161 201 34.5
.5 Peripheral circulatory complications 0 7 0 0 61 68 11.7
.6 Other specified complications 0 0 1 0 0 1 0.2
.7 Multiple complications 1 6 1 0 44 52 8.9
.8 Unspecified complications 0 1 0 0 22 23 3.9
.9 No complications 5 24 0 0 199 228 39.1
N total 12 75 2 0 494 583 100
% 2.1 12.9 0.3 0 84.7 100
Source: Epidemiological Surveillance Division of the Municipal Secretariat of Ribeirão Preto.
a E10 – insulin-dependent diabetes mellitus.
b E11 – non-insulin-dependent diabetes mellitus.
c E12 – malnutrition-related diabetes mellitus.
d E13 – other specified types of diabetes mellitus.
e E14 – unspecified diabetes mellitus. 
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Regarding sex, women had a mean of 64.2 deaths/year, and men had a mean of 52.4 deaths/
year. Regarding ASMR, there was a 38.5% increase from the first to the last year of the study, 
in both sexes (Table 3).
Among 583 deaths, 229 (39.3%) were considered premature. Among premature deaths, 129 
(22.1%) were male. The average PYLL was 10.4 years (Table 4).
Table 2. Absolute number (n), percentage (%) and age-standardized mortality rate (ASMR) distribution for diabetes mellitus deaths of Ribeirão 
Preto residents, 2010 to 2014, according to sex and age group. Ribeirão Preto, state of São Paulo, Brazil, 2017. 
Age group













0–4 0 0 0.0 0 0 0.0 0 0 0.0
5–9 1 0.2 0,4 0 0 0.0 1 0.2 0.2
10–14 0 0 0.0 0 0 0.0 0 0 0.0
15–19 0 0 0.0 1 0.2 0.4 1 0.2 0.2
20–24 1 0.2 0.3 1 0.2 0.3 2 0.3 0.3
25–29 1 0.2 0.3 1 0.2 0.3 2 0.3 0.3
30–34 2 0.3 0.6 0 0 0.0 2 0.3 0.3
35–39 5 0.9 1.6 1 0.2 0.3 6 1.0 1.0
40–44 4 0.7 1.3 8 1.4 2.4 12 2.1 1.9
45–49 4 0.7 1.3 1 0.2 0.3 5 0.9 0.7
50–54 10 1.7 3.2 9 1.5 2.4 19 3.3 2.8
55–59 30 5.2 9.8 14 2.4 3.8 44 7.6 6.6
60–64 31 5.3 10.9 35 6.0 9.8 66 11.3 10.3
65–69 43 7.4 16.9 32 5.5 9.6 75 12.9 12.8
70–74 34 5.8 13.3 31 5.3 8.5 65 11.2 10.5
75–79 34 5.8 13.3 55 9.4 13.9 89 15.3 13.7
80+ 62 10.6 24.8 132 22.7 26.9 194 33.3 26.2
Total 262 44.9 90.3 321 55.1 102.1 583 100 96.4
Source: Epidemiological Surveillance Division of the Municipal Secretariat of Ribeirão Preto.
Table 3. Absolute number (n), percentage (%), and age-standardized mortality rate (ASMR) distribution for 
diabetes mellitus deaths of Ribeirão Preto residents, 2010 to 2014, according to sex and year. Ribeirão 
Preto, state of São Paulo, Brazil, 2017.
Year













2010 47 8.1 17.5 57 9.8 14.1 104 17.8 15.6
2011 51 8.7 19.2 46 7.9 11.5 97 16.6 14.7
2012 54 9.3 20.3 69 11,8 17.0 123 21.1 18.5
2013 51 8.7 19.1 63 10.8 15.4 114 19.6 17.2
2014 59 10.2 21.8 86 14.7 20.9 145 24.9 21.6
Source: Epidemiological Surveillance Division of the Municipal Secretariat of Ribeirão Preto.
Table 4. Absolute number (n), percentage (%), age-standardized mortality rate (ASMR), and potential years of life lost (PYLL) distribution 
for premature deaths (30–69 years) of Ribeirão Preto residents due to diabetes mellitus, 2010 to 2014, according to sex and year. Ribeirão 
Preto, state of São Paulo, Brazil, 2017.
Year
Male sex Female sex Total






















2010 24 4.1 8.5 243 10.2 10.1 16 2.7 4.6 207 8.7 12.9 40 6.9 6.3 450 18.8 11.3
2011 25 4.3 8.9 270 11.3 10.8 15 2.6 4.2 142 5.9 9.5 40 6.9 6.3 412 17.3 10.3
2012 23 3.9 8.2 271 11.4 11.8 22 3.8 6.2 227 9.5 10.3 45 7.7 7.1 498 20.9 11.1
2013 26 4.5 9.2 260 10.9 10 17 2.9 4.9 133 5.6 7.8 43 7.4 6.9 393 16.5 9.1
2014 31 5.3 10.7 349 14.6 11.3 30 5.2 8.7 285 11.9 9.5 61 10.5 9.6 634 26.6 10.4
Total 129 22.1 45.5 1,393 58.4 10.8 100 17.2 28.6 994 41.6 9.9 229 39.3 36.2 2,387 100 10.4
Source: Division of Epidemiological Surveillance of the Municipal Secretariat of Ribeirão Preto.
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DISCUSSION
The municipality saw a total of 583 DM deaths during the studied period, and an increase 
in ASMR from 15.6 per 100,000 inhabitants in 2010 to 21.6 in 2014. The Global Burden 
of Disease study carried out in 195 countries showed that there was an increase in DM 
mortality in Brazil from 1990 to 2015, as well as an increase in ASMR – from 35.9 per 100,000 
inhabitants in 1990 to 37.5 in 201516. Despite the mortality rate increase shown here, our 
results for Ribeirão Preto (21.6 per 100,000 inhabitants in 2014) are still below the national 
average. In contrast, a Canadian study showed an approximately one-quarter decline in 
age-standardized DM mortality between 1995 and 200517.
This study found that the main specific causes of death due to DM were renal complications, 
responsible for 34.5% of deaths, peripheral circulatory complications, 11.7%, and multiple 
complications, 8.9%. For 39.1% of deaths, no complications were reported. A Brazilian study 
evaluating DM mortality between 1996 and 2011, including 294,203 deaths, showed that renal 
complications (19.1%) and peripheral circulatory complications (6.1%) were the main specific 
causes of death from DM. It is noteworthy that 7% of the deaths were due to unspecified 
complications. In the majority (51.9%) of DM deaths in the period, there were no complications18.
Acute complications, ketoacidosis and coma accounted for only 1.7% of deaths, which 
is consistent with the literature19, and confirms that the free supply of insulin and other 
necessities to people with DM was a milestone of the Brazilian health system19. When 
analyzing the obtained results, the higher DM mortality in the female sex (55.1% of deaths) 
stood out. This percentage was similar to the one found by a Brazilian nationwide study 
(57.7%) which described DM mortality from 1980 to 20124.
From 2010 to 2014, there was a yearly average ASMR increase of 7% (from 15.5 to 21.6 per 
100,000 inhabitants), affecting both sexes. In the same period, the average increase for the 
male sex was 4% per year (from 17.5 to 21.8 per 100,000 inhabitants), while for the female 
sex it was 8% per year (from 14.1 to 20.9 per 100,000 inhabitants). The results found here 
are in agreement with another Brazilian, ecological and time-series study, which evaluated 
the pattern of DM mortality according to sex from 1980 to 20124. However, despite the 
fact that in the aforementioned study ASMR also increased for both sexes, the increase 
rates were lower: 2.9% per year for men (20.8 per 100,000 inhabitants in 1980 to 47.6 in 
2012) and 1.7% per year for women (28.7 per 100,000 inhabitants in 1980 to 47.2 in 2012). 
The study also showed that towards the end of the 1980–2012 period this relationship 
was reversed, with female mortality higher in the initial years of the survey and male 
mortality higher in its final years4. The ASMR distribution according to sex found by this 
study showed higher values for men than for women, in all the evaluated years. However, 
between 2010 and 2014 the yearly increase in average female DM mortality was double 
that of men, which points to a possible reversal in the future, with higher DM ASMR in 
the female sex.
ASMR rates increased gradually with age, for both sexes, indicating a dependence on 
population aging. Among deaths in the female sex, 132 (22.7%) were in the 80 years or more 
age group, more than double the number of male deaths in the same age group (62, 10.6%). 
According to estimates by the International Diabetes Federation (2015), women had a greater 
incidence and prevalence of DM at the apex of their aging when compared to males with 
the same age and, therefore, a higher mortality rate in the higher age groups3. This may be 
explained by the higher number of premature deaths attributed to external causes in males, 
a preeminent feature of developing countries, leading to greater survival rates in females, 
as observed in other studies3,16,20–23. A study evaluated 264 causes of death, including DM, 
in 195 countries from 1980 to 2016, and found that DM deaths in older people over 70 years 
of age increased by approximately 90% throughout the studied period24. 
We found an average PYLL loss of 10 years for each premature death (at 30 to 69 years of 
age), that is, DM withdrew 10 years of economically active life from each person who died 
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from the disease. Therefore, premature deaths together with PYLL strengthen the impact 
of DM on individuals, families, communities and the country, as it overburdens health 
services and causes early retirement, harming economic development3.
Our study also found an increase in premature mortality rates. The average increase was 5% 
per year for men (8.5 to 10.7 per 100,000 inhabitants), 14% for women (4.6 to 8.7 per 100,000 
inhabitants) and 9% for both sexes (6.3 to 9.6 per 100,000 inhabitants). However, a national 
study showed a decline in the rate of premature DM mortality in Brazil, which went from 
40.6 per 100,000 inhabitants in 2000 to 33.7 in 2011 (a 1.7% yearly reduction). The study 
projected a drop to 26.9 per 100,000 inhabitants by 202214. 
The goal of the national plan for tackling CNCDs is to reduce premature mortality rate to 
2% a year7, which has not yet been achieved. Thus, although the municipality of Ribeirão 
Preto, had a marked ASMR increase in both premature and overall deaths – and mainly 
in the female sex – local death rates were still lower than the national averages. These 
discrepancies suggest that a general increase in the incidence and prevalence of DM is 
occurring. A plausible explanation for this situation is the disorganized industrial and 
urban growth of most Brazilian municipalities, coupled with the adoption of harmful life 
habits by the majority of the population, which increase the likelihood of developing chronic 
diseases such as DM25. 
The deleterious long-term effects of hyperglycemia on people suffering from DM, associated 
with the increase in premature mortality, calls for reflection on public health policies, in 
order to propose effective interventions against DM. Thus, this study may contribute to 
advances in local health diagnosis, and serve as basis for new subsidies towards preventive 
and health promotion measures, with a consequent reduction in the rates of premature 
mortality and DM mortality26. 
Another study described mortality rates in all Brazilian capitals, from 1980 to 200727, and 
observed increases in ASMR mainly in North and Northeast capitals. The city of Porto Velho, 
state of Rondônia, had an ASMR of 9.76 per 100,000 inhabitants in the first four years, and 
this number increased to 46.13 in the last four years. In São Luís, state of Maranhão, ASMR 
increased from 24.75 in the first quadrennium to 54.38 in the last. 
In the Southeastern region, two capitals had a decline in ASMR: Belo Horizonte, state 
of Minas Gerais, and São Paulo, state of São Paulo, with a drop from 28.82 per 100,000 
inhabitants in the first four-year period to 18.36 in the last, and from 28.94 in the first four-
year period to 22.05 in the last, respectively27. These data, however, differs from the results 
of our study, which, although performed in the same geographic region, showed an increase 
in ASMR during the evaluated period. 
Accessibility to health services may be a determining factor of such macro-regional 
contrasts. In fact, a nationwide study28 on the population’s access to primary care teams 
certified by the National Program for Access and Quality Improvement in Primary Care 
(PMAQ-AB) found a greater possibility of access in the Southeast, a lesser possibility in 
the North, and a greater concentration of family health teams in the capitals28. These data 
highlight the relevance of studies such as ours and the need for future research analyzing 
DM mortality rates and other CNCDs in medium or small municipalities. 
One of this study’s limitations was the underreporting of the disease in death certificates, 
which may have led to an underestimation of DM mortality rates. Also, there was no 
investigation and redistribution of possible insufficiently defined causes of death related 
to endocrine diseases, as performed in other studies14,18,29. Another limitation of this study 
is the impossibility of describing mortality according to specific DM types, since the 
majority of the deaths were classified as E14 (84.7%)19. In order to reduce underreporting, 
it is necessary to reinforce the importance of adequate completion of the death certificate 
by the physician. Furthermore, epidemiological surveillance teams trained in monitoring 
all spheres have to be implemented, in order to investigate insufficiently defined causes30. 
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In conclusion, the results show that DM mortality in the city of Ribeirão Preto, state of 
São Paulo, Brazil increased in the 2010 to 2014 period. There was a higher occurrence of 
deaths in females, but ASMRs were higher in males. As to age, there was a predominance 
of deaths in the 80 years or more age group. For both sexes, there was an annual mean 
increase of 9% in premature mortality during the studied period. DM deaths are 
responsible for the withdrawal of 10 years of life expectancy. These results may support 
public policies in the prevention of DM mortality, as well as health promotion towards 
adult individuals with DM.
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